Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab vs Ranibizumab + Triamcinolone for Macular Edema in CRVO
NCT04460001Phase 3Unknown
- Sponsor
- Assiut University
- Start
- May 2019
- Primary completion
- Aug 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone in macular edema, sponsored by Assiut University. Status: unknown.
02
Drugs
triamcinolone
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT04460001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04460001.